Home/Tag: Vitassay

Monkeypox Alert!

Monkeypox is a zoonosis first described in a human patient in 1970, when the virus was isolated from a 9-month-old patient with smallpox suspicion in the Democratic Republic of Congo. It is a neglected endemic zoonotic disease in the tropical rainforest regions of Central and West Africa. In 2003, the first outbreak of Monkeypox virus [...]

By |2022-08-05T08:18:58+00:00August 5th, 2022|Sin categoría|Comments Off on Monkeypox Alert!

AACC 2022 – What a successful exhibition!

Vitassay Healthcare attended AACC 2022 at McCormick Place Convention Center (Chicago, US). Our team was able to introduce the new turbidimetry, CLIA and qPCR products to our customers from all over the world. In addition, two posters were presented in which the advantages of Vitassay qPCR were highlighted. We are already preparing the next exhibition: [...]

By |2022-08-05T08:11:42+00:00August 2nd, 2022|Sin categoría|Comments Off on AACC 2022 – What a successful exhibition!

MEDLAB Middle East 2022

From January 24 to 27, Vitassay will be present once again at the MEDLAB Middle East Exhibition at Dubai. Again, the greatest precautionary measures have been taken so that visitors and exhibitors enjoy a positive and safe experience. Vitassay Healthcare, faithful to this appointment, will be present at its stand number Z5.F01, showing its entire [...]

By |2021-12-07T08:46:10+00:00December 7th, 2021|Sin categoría|Comments Off on MEDLAB Middle East 2022

MEDICA 2021

After the 2020 stoppage due to the COVID-19 pandemic, Vitassay will once again be present at MEDICA, the largest and most important world fair for the medical sector, which brings together more than 6,000 exhibitors from five continents. Vitassay recovers the space it already had in 2019, where it will present its latest innovations in [...]

By |2021-11-09T11:21:44+00:00November 9th, 2021|Sin categoría|Comments Off on MEDICA 2021

AACC 2021

Next September 28, 29 and 30, Vitassay will be present in the new AACC edition that, after a blank year due to a pandemic, returns with force to Atlanta. The firm will present its new releases focused on the diagnosis of infectious diseases, with special attention to the latest developments for the SARS-CoV-2 detection and [...]

By |2021-08-31T09:49:39+00:00August 31st, 2021|Sin categoría|Comments Off on AACC 2021

New SARS-CoV-2 Variants II RT-PCR assay

New Real-time PCR kit for the qualitative detection of RNA from genetic mutations in the S gene (P681R, L452R and E484Q) in positive SARS-CoV-2 respiratory samples. Despite the slow evolutionary rate of SARS-CoV-2 relative to other RNA viruses, its massive and rapid transmission during the COVID-19 pandemic has enabled it to acquire significant genetic diversity [...]

By |2021-07-13T14:30:23+00:00July 13th, 2021|Sin categoría|Comments Off on New SARS-CoV-2 Variants II RT-PCR assay

MEDLAB Middle East 2021

From June 21 to 24, Vitassay will be exhibiting its latest releases at the MEDLAB Middle East 2021 Exhibition. The SARS-CoV-2 pandemic forced to delay this appointment, which usually takes place at the beginning of the year. This time, the greatest precautionary measures have been taken so that visitors and exhibitors will enjoy a positive [...]

By |2021-06-16T10:45:29+00:00June 16th, 2021|Sin categoría|Comments Off on MEDLAB Middle East 2021

New respiratory multitest

The new Vitassay SARS-CoV-2 + Flu A + B + RSV + Adeno Resp. is a rapid, immunochromatographic assay for the simultaneous qualitative detection of nucleoprotein antigen of SARS-CoV-2, Influenza type A, Influenza type B, RSV and Adenovirus from nasopharyngeal swabs samples from patients suspected of COVID-19 infection and/or Influenza A and/or Influenza B and/or [...]

By |2020-10-19T12:09:14+00:00October 19th, 2020|Sin categoría|Comments Off on New respiratory multitest

New qPCR assay for Tuberculosis

The new Vitassay qPCR MTBC/NTM assay is intended for use in the diagnosis of the M. tuberculosis complex (MTBC), the genus mycobacterium, and the specie M. tuberculosis infections alongside clinical data of the patient and other laboratory tests outcomes. Tuberculosis mostly affects adults in their most productive years. However, all age groups are at risk. [...]

By |2020-10-19T11:11:04+00:00October 19th, 2020|Sin categoría|Comments Off on New qPCR assay for Tuberculosis
Go to Top